• Home
  • Search Results
  • Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.

Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.

BMC cancer (2009-01-30)
Louise A Knight, Christian M Kurbacher, Sharon Glaysher, Augusta Fernando, Ralf Reichelt, Susanne Dexel, Uwe Reinhold, Ian A Cree
ABSTRACT

Previous data suggest that lipophilic statins such as fluvastatin and N-bisphosphonates such as zoledronic acid, both inhibitors of the mevalonate metabolic pathway, have anti-cancer effects in vitro and in patients. We have examined the effect of fluvastatin alone and in combination with zoledronic acid in the ATP-based tumour chemosensitivity assay (ATP-TCA) for effects on breast and ovarian cancer tumour-derived cells. Both zoledronic acid and fluvastatin showed activity in the ATP-TCA against breast and ovarian cancer, though fluvastatin alone was less active, particularly against breast cancer. The combination of zoledronic acid and fluvastatin was more active than either single agent in the ATP-TCA with some synergy against breast and ovarian cancer tumour-derived cells. Sequential drug experiments showed that pre-treatment of ovarian tumour cells with fluvastatin resulted in decreased sensitivity to zoledronic acid. Addition of mevalonate pathway components with zoledronic acid with or without fluvastatin showed little effect, while mevalonate did reduced inhibition due to fluvastatin. These data suggest that the combination of zoledronic acid and fluvastatin may have activity against breast and ovarian cancer based on direct anti-cancer cell effects. A clinical trial to test this is in preparation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ficoll® solution, Type 400, 20% in H2O
Sigma-Aldrich
Ficoll® 400, BioXtra, for molecular biology, lyophilized powder
Sigma-Aldrich
Farnesol, 95%
Sigma-Aldrich
Ficoll® 400, lyophilized powder, Type 400-DL, BioReagent, suitable for cell culture
Sigma-Aldrich
Ficoll® 400, Type 400-DL, lyophilized powder
Sigma-Aldrich
Geranylgeraniol, ≥85% (GC)
Sigma-Aldrich
Farnesol, mixture of isomers, ≥95%, stabilized, FG
Sigma-Aldrich
Collagenase from Clostridium histolyticum, Sigma Blend Type H, ≥1.0 FALGPA units/mg solid
Sigma-Aldrich
Ficoll® 400, lyophilized powder, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
Ficoll® 400, BioXtra, Type 400-DL, lyophilized powder